Pugliese, Marco,Mahy Gehenne, Josette-Nicole,Rodriguez Allue, Manuel,Espinosa Parrilla, Juan Francisco,Virgili Treserres, Noemi,Mancera Aroca, Pilar,Pasten Zamorano, Andrea
申请号：
AU2011203402
公开号：
AU2011203402A1
申请日:
2011.01.04
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
The invention relates to the use of diazoxide or a pharmaceutically acceptable salt thereof at low doses to treat a CNS autoimmune demyelinating disease selected from selected from multiple sclerosis (MS), clinically isolated syndrome (CIS), tumefactive (tumor-like) MS, Marburg's acute MS, Balόs's concentric sclerosis, acute disseminated encephalomyelitis (ADEM), post-vaccinal encephalitis (PVE), post-infectious encephalomyelitis (PIE) and neuromyelitis optica (NMO).
